Summary

Listen to our talk during this virtual event on Next-Generation Transfection Reagent for Large Scale AAV Manufacturing.

Our team

Jean-Thomas ISSENHUTH
 Jean-Thomas ISSENHUTH 
 Business Manager EMEA 
About Jean-Thomas ISSENHUTH
Business Manager EMEA
Aucune information.
Mégane Denu
 Mégane Denu 
 R&D Engineer Bioproduction 
About Mégane Denu
R&D Engineer Bioproduction
Aucune information.
Cassie-Marie Peigné
 Cassie-Marie Peigné 
 Scientific Support Specialist 
About Cassie-Marie Peigné
Scientific Support Specialist
Aucune information.

Talk: Next-Generation Transfection Reagent for Large Scale AAV Manufacturing

Transient transfection of suspension cells is the most commonly used production platform for AAV manufacturing. However, this method shows some limitations in large scale bioreactors: inadequate transfection protocol, reduced transfection efficiency and lower productivity. To address this concern, we present data on the novel transfection reagent showing: i) increased AAV titers, ii) improved transfection protocol for large scale bioreactors and iii) reproducibility of viral titers at different production scale.

Presented by: Mégane Denu, R&D Engineer Bioproduction at Polyplus-transfection®
, 11:40

 

Our solutions for both protein and virus production

NEW! FectoVIR®-AAV: for Recombinant AAV virus production in suspension cells.

PEIpro® product range for a scalable viral vector production for Gene & Cell therapy.

FectoPRO® Transfection kit is specifically designed for enhanced Transient Gene Expression (TGE) in suspension CHO and HEK-293 cells in various serum-free media, using low DNA amount (< 1 µg/ml of cell culture).

 

General information

Registration link for virtual event: click here

Give your feedback!